Company / Total Assets
Spyre Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$777.8M
FY2025
5-year range
$71.1M / $777.8M
FY2021-FY2025
Trend
+27.8%
vs FY2024
Sector context
#97 of 214
Health Care
What the data says
At $778M, Spyre Therapeutics, Inc.'s total assets ranks #97 of 214 in the Health Care sector. Total Assets has increased for 3 consecutive years, from $71M in FY2022 to $778M in FY2025.
Based on SEC 10-K filings.
$778M in FY2025 with a 5-year CAGR of +36.9%.
Improved from $342M to $778M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +121.9%
- 5-Year CAGR
- +36.9%
- 10-Year CAGR
- -
Sector benchmark
#97 of 214 in Health CareTop 45% of 214This company $777.8M Sector average $7.5B
▼
-89.6% below sector average
Key checks
Key Insights
- Spyre Therapeutics, Inc.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +36.9%, indicating consistent growth.
- In FY2025, total assets increased 27.8% year-over-year.
- Ranks #97 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $777.8M | +27.8% |
| FY2024 | $608.5M | +78.0% |
| FY2023 | $341.9M | +380.5% |
| FY2022 | $71.1M | -35.3% |
| FY2021 | $109.9M | -32.0% |
| FY2020 | $161.6M | +94.3% |
| FY2019 | $83.2M | +7.0% |
| FY2018 | $77.7M | +38.6% |
| FY2017 | $56.1M | -16.4% |
| FY2016 | $67.1M | +73.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026